BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21805729)

  • 21. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
    Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant transformation of hepatocytes and the specific biomarkers for hepatocellular carcinoma].
    Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):244-6. PubMed ID: 21805730
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
    Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Well-differentiated hepatocellular carcinoma].
    Umeshita K; Sakon M; Hasuike Y; Kanai T; Gotoh M; Monden M; Wakasa K; Sakurai M
    Ryoikibetsu Shokogun Shirizu; 1995; (7):470-2. PubMed ID: 8749528
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pedunculated (exophytic) hepatocellular carcinoma--a report of two cases].
    Wu G; Huang JZ; Gu HG
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):490. PubMed ID: 16042880
    [No Abstract]   [Full Text] [Related]  

  • 27. [MR image of early hepatocellular carcinoma and hepatocellular carcinoma with early components].
    Muramatsu Y; Nawano S; Moriyama N; Takayasu K
    Nihon Rinsho; 1991 Aug; 49(8):1815-20. PubMed ID: 1664886
    [No Abstract]   [Full Text] [Related]  

  • 28. [Screening of serum biomarkers in hepatocellular carcinoma by SELDI technique: a preliminary study].
    Yao DK; Zhu L; Wang WJ; Song ST
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):298-9. PubMed ID: 17456321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fibrolamellar carcinoma of the liver. Apropos of 2 cases. Review of the literature].
    Azais-Noblinski B; Dahan D; Tubiana JM
    Ann Radiol (Paris); 1987; 30(6):395-9. PubMed ID: 2834992
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fibrolamellar carcinoma of the liver].
    Schechter D; Shefer R; Yosipov J; Inbar M; Messer G; Lelcuk S
    Harefuah; 1987 Oct; 113(7-8):160-1. PubMed ID: 2828202
    [No Abstract]   [Full Text] [Related]  

  • 33. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E; Kaneko S; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiological diagnosis and staging of hepatocellular carcinoma.
    Koito K; Suga T; Murashima Y
    Endoscopy; 1993 Jan; 25(1):131-7. PubMed ID: 8384101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fibrolamellar hepatocellular cancer].
    Ormann W
    Leber Magen Darm; 1993 May; 23(3):128-31. PubMed ID: 8392127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and staging of hepatocellular carcinoma prior to transplantation: expertise or failure.
    Varela M; Forner A; Bruix J
    Liver Transpl; 2006 Oct; 12(10):1445-7. PubMed ID: 17004255
    [No Abstract]   [Full Text] [Related]  

  • 37. Specific molecular markers in hepatocellular carcinoma.
    Yao DF; Dong ZZ; Yao M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of pedunculated hepatoma suspected of adrenal tumor].
    Hanai T; Miyatake R; Hashimoto K; Kato Y; Iguchi M
    Hinyokika Kiyo; 1999 Jun; 45(6):411-3. PubMed ID: 10442283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capsular formation surrounding hepatocellular carcinoma.
    Iwamura K
    Tokai J Exp Clin Med; 1986 Aug; 11(3):185-99. PubMed ID: 3039694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific expression of osteopontin and S100A6 in hepatocellular carcinoma.
    Hua Z; Chen J; Sun B; Zhao G; Zhang Y; Fong Y; Jia Z; Yao L
    Surgery; 2011 Jun; 149(6):783-91. PubMed ID: 21310450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.